Previous studies have established high expression of AKR1B10 in several cancers, including cholangiocarcinoma, hepatocellular carcinoma, lung adenocarcinoma, lung squamous cell carcinoma, prostate cancer, and uterine endometrial cancer, compared to adjacent normal tissues. This evidence concerns the gene AKR1B10 and cholangiocarcinoma.